All Stocks
pharma

GILD — Gilead Sciences Inc.

Conviction32
Congress 90d1
Insider 90d0
Markets0
Lobbying3
Contracts0
CountryUS

GILD

Gilead Sciences Inc.

pharma
32thin · 2 src Bullish2 sources agree
🏛 Congress📋 Lobbying

Congressional trades

Last 90 days
1 buy0 sell1 legislator
  • buy Jared Moskowitz$1K–$15K · May 6, 2026

Prediction markets

No prediction markets reference this stock.

Lobbying filings

Last 2 years
  • FORBES-TATE$90K · 2026 first_quarter
    HCR
  • EMPIRE CONSULTING GROUP$50K · 2026 first_quarter
    HCR
  • B HALL STRATEGIES, LLC$30K · 2026 first_quarter
    PHA

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States67/100
Posture: neutralView United States

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

No federal contract awards matched this company.

ebea842